Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Humacyte
HUMA
$194M
| $276K | ﹤0.01% |
97,187
+73,399
| +309% | +$188K |
|
4152
Red Robin
RRGB
$152M
| $274K | ﹤0.01% |
22,004
+19,245
| +698% | +$179K |
|
|
ONIT
4153
Onity Group
ONIT
$332M
| $274K | ﹤0.01% |
8,907
+7,720
| +650% | +$198K |
|
4154
PCB Bancorp
PCB
$392M
| $274K | ﹤0.01% |
14,843
+13,053
| +729% | +$211K |
|
4155
Brookfield Renewable
BEP
$9.96B
| $273K | ﹤0.01% |
10,398
+6,195
| +147% | +$147K |
|
|
BCYC
4156
Bicycle Therapeutics
BCYC
$292M
| $272K | ﹤0.01% |
15,032
+14,864
| +8,848% | +$246K |
|
4157
Pulse Biosciences
PLSE
$2.94B
| $271K | ﹤0.01% |
22,178
+19,187
| +641% | +$133K |
|
4158
CS Disco
LAW
$279M
| $271K | ﹤0.01% |
35,746
+27,496
| +333% | +$173K |
|
4159
InfuSystem Holdings
INFU
$249M
| $270K | ﹤0.01% |
25,638
+21,706
| +552% | +$213K |
|
4160
NuScale Power
SMR
$4.03B
| $270K | ﹤0.01% |
82,112
+67,306
| +455% | +$239K |
|
4161
Richardson Electronics
RELL
$304M
| $270K | ﹤0.01% |
20,231
+14,662
| +263% | +$175K |
|
|
AFCG
4162
AFC Gamma
AFCG
$63.4M
| $270K | ﹤0.01% |
32,795
+28,517
| +667% | +$225K |
|
4163
CALL
RLX Technology
RLX
$2.46B
| $270K | ﹤0.01% |
135,000
-365,000
| -73% | -$679K |
|
4164
ODDITY Tech
ODD
$651M
| $270K | ﹤0.01% |
+5,794
| New | +$196K |
|
4165
Ranger Energy Services
RNGR
$377M
| $268K | ﹤0.01% |
26,199
+21,486
| +456% | +$248K |
|
4166
Chemung Financial Corp
CHMG
$392M
| $268K | ﹤0.01% |
5,379
+4,133
| +332% | +$183K |
|
4167
First Western Financial
MYFW
$306M
| $267K | ﹤0.01% |
13,458
+10,601
| +371% | +$179K |
|
4168
Tyra Biosciences
TYRA
$1.58B
| $266K | ﹤0.01% |
19,227
+16,721
| +667% | +$216K |
|
|
ORAN
4169
DELISTED
Orange
ORAN
| $266K | ﹤0.01% |
23,241
-333,904
| -93% | -$3.92M |
|
4170
Ovid Therapeutics
OVID
$491M
| $264K | ﹤0.01% |
82,060
+71,280
| +661% | +$244K |
|
4171
American Public Education
APEI
$940M
| $264K | ﹤0.01% |
27,366
+15,496
| +131% | +$98.5K |
|
|
NVTA
4172
DELISTED
Invitae Corporation
NVTA
| $264K | ﹤0.01% |
421,240
-484,291
| -53% | -$290K |
|
|
CMLS
4173
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $262K | ﹤0.01% |
49,337
| – | – |
|
|
EFXT
4174
Enerflex
EFXT
$2.44B
| $262K | ﹤0.01% |
56,193
+29,386
| +110% | +$128K |
|
4175
PUT
BridgeBio Pharma
BBIO
$16.5B
| $262K | ﹤0.01% |
+6,500
| New | +$195K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.